Skip to main content
Premium Trial:

Request an Annual Quote

IMDx Assays for Abbott Platform Gain Licensure in Canada, Singapore

NEW YORK (GenomeWeb) — IMDx said today that it has received three additional licenses for sale and distribution of its molecular tests for the Abbott m2000 platform outside the US and EU.

First, the IMDx C. difficile assay for the qualitative detection of toxigenic Clostridium difficile toxin A and B genes, and the Flu A/B and RSV assay for the qualitative detection of influenza A, influenza B, and respiratory syncytial virus have been approved by Health Canada for sale and distribution in Canada.

In addition, the IMDx C. difficile assay has been approved by the Health Sciences Authority for sale and distribution in Singapore, IMDx said.

These tests join the previously licensed IMDx VanR for Abbott m2000 assay in the company's portfolio of tests commercially available in Canada and Singapore.

IMDx, based in Waltham, Mass., has been developing real-time tests for the Abbott m2000 testing system under a multi-year agreement signed between the companies in 2011.

Several such tests have already been CE marked or approved by the US Food and Drug Administration, and IMDx said this week that it has been placing "significant focus" on obtaining international licenses to globally distribute and sell these products.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.